Glycogen storage disease type IIIa in curly-coated retrievers

Journal of Veterinary Internal Medicine

Volumn 21, Issue 1, 2007, Pages 40-46

  Gregory, Brittany L ^a   Diane Shelton, G ^c,d   Bali, Deeksha S ^e,f   Chen, Yuan Tsong ^e,f   Fyfe, John C ^a,b,c  

^a Laboratory of Comparative Medical Genetics   (United States)

^b Department of Small Animal Clinical Sciences ^*  (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d School of Medicine   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f DUKE UNIVERSITY   (United States)

Author keywords

Genetic test; Inborn error; Liver muscle; Metabolism; Mutation

Indexed keywords

ANIMAL; ANIMAL DISEASE; ARTICLE; DOG; DOG DISEASE; FEMALE; GENETIC PREDISPOSITION; GENETICS; GLYCOGEN STORAGE DISEASE TYPE 3; LIVER; MALE; PATHOLOGY; PEDIGREE; SKELETAL MUSCLE;

ANIMALS; DOG DISEASES; DOGS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLYCOGEN STORAGE DISEASE TYPE III; LIVER; MALE; MUSCLE, SKELETAL; PEDIGREE;

ANIMALIA; CANIS FAMILIARIS;

EID: 33847050256     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2007)21[40:GSDTII]2.0.CO;2     Document Type: Article

References (28)

1. Chen Y-T. Glycogen storage diseases. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease, 8th ed. New York, NY: McGraw Hill; 2001;1521-1551.
2. Kishnani PS, Faulkner E, VanCamp S, et al. Canine model and genomic structural organization of glycogen storage disease type la (GSD Ia), Vet Pathol 2001;38:83-91.
3. Walvoort HC, Dormans JA, van den Ingh TS. Comparative pathology of the canine model of glycogen storage disease type II (Pompe's disease). J Inherit Metab Dis 1985;8:38-46.
4. Ceh L, Hauge JG, Svenkerud R, Strande A. Glycogenosis type III in the dog. Acta Vet Scand 1976;17:210-222.
5. Rafiquzzaman M, Svenkerud R, Strande A, Hauge JG. Glycogenosis in the dog. Acta Vet Scand 1976;17:196-209.
6. Giger U, Argov Z, Schnall M, et al. Metabolic myopathy in canine muscle-type phosphofructokinase deficiency. Muscle Nerve 1988;11:1260-1265.
7. Kishnani PS, Bao Y, Wu JY, et al. Isolation and nucleotide sequence of canine glucose-6-phosphatase mRNA: Identification of mutation in puppies with glycogen storage disease type Ia. Biochem Mol Med 1997;61:168-177.
8. Smith BF, Stedman H, Rajpurohit Y, et al. Molecular basis of canine muscle type phosphofructokinase deficiency. J Biol Chem 1996;271:20070-20074.
9. Beaty RM, Jackson M, Peterson D, et al. Delivery of glucose-6-phosphatase in a canine model for glycogen storage disease, type la, with adeno-associated virus (AAV) vectors. Gene Ther 2002;9:1015-1022.
10. Liu W, Madsen NB, Braun C, Withers SG. Reassessment of the catalytic mechanism of glycogen debranching enzyme. Biochemistry 1991;30:1419-1424.
11. Markowitz AJ, Chen Y-T, Muenzeer J, et al. A man with type III glycogenosis associated with cirrhosis and portal hypertension. Gastroenterology 1993;105:1882-1885.
12. Momoi T, Sano H, Yamanaka C, et al. Glycogen storage disease type III with muscle involvement: reappraisal of phenotypic variability and prognosis. Am J Med Genet 1992;42:696-699.
13. Dickinson PJ, LeCouteur RA. Muscle and nerve biopsy. Vet Clin North Am Small Anim Pract 2002;32:63-102.
14. Brix AE, Howerth EW, McConkie-Rosell A, et al. Glycogen Storage disease type la in two littermate Maltese puppies. Vet Pathol 1995;32:460-465.
15. Yang BZ, Ding JH, Brown BI, Chen YT. Definitive prenatal diagnosis for type III glycogen storage disease. Am J Hum Genet 1990;47:735-739.
16. Fyfe JC, Kampschmidt K, Dang V, et al. Congenital hypothyroidism with goiter in toy fox terriers. J Vet Intern Med 2003;17:50-57.
17. Altschul SF, Gish W, Miller W, et al. Basic local alignment search tool. J Mol Biol 1990;215:403-410.
18. Sambrook J, Russel DW. Molecular Cloning: A Laboratory Manual, 3rd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 2001:7.31-7.44.
19. Bao Y, Dawson TL Jr, Chen Y-T. Human glycogen debranching enzyme gene (AGL): Complete structural organization and characterization of the 5′ flanking region. Genomics 1996;38:155-165.
20. Hoffman EP, Clemens PR. HyperCKemic, proximal muscular dystrophies and the dystrophin membrane cytoskeleton, including dystrophinopathies, sarcoglycanopathies, and merosinopathies. Curr Opin Rheumatol 1996;8:528-538.
21. Carbone I, Bruno C, Sotgia F, et al. Mutation in the CAV3 gene causes partial caveolin-3 deficiency and hyperCKemia. Neurology 2000;54:1373-1376.
22. Capasso M, Lupo S, Di Muzio A, et al. Immunohisto-chemical study of caveolin-3 in idiopathic hyperCKaemia. J Neurol Neurosurg Psychiatry 2003;74:547-548.
23. Capasso M, De Angelis MV, Di Muzio A, et al. Familial idiopathic hyper-CK-emia: An underrecognized condition. Muscle Nerve 2006;33:760-765.
24. Bruno C, Bertini E, Santorelli FM, DiMauro S. HyperCKemia as the only sign of McArdle's disease in a child. J Child Neurol 2000;15:137-138.
25. Braun C, Lindhorst T, Madsen N, Withers SG. Identification of Asp 549 as the catalytic nucleophile of glycogendebranching enzyme via trapping of the glycosyl-enzyme intermediate. Biochemistry 1996;35:5458-5463.
26. Nakayama A, Yamamoto K, Tabata S. Identification of the catalytic residues of bifunctional glycogen debranching enzyme. J Biol Chem 2001;276:28824-28828.
27. Yang BZ, Ding JH, Enghild JJ, et al. Molecular cloning and nucleotide sequence of cDNA encoding human muscle glycogen debranching enzyme. J Biol Chem 1992:267:9294-9299.
28. Mendell JT, Dietz HC. When the message goes awry: Disease-producing mutations that influence mRNA content and performance. Cell 2001;107:411-414.